A diagnosis of skin cancer is difficult. A diagnosis of melanoma, just plain melanoma, is more difficult. And a diagnosis of malignant melanoma may be the worst of all cancer diagnoses. I said “may be” as in this diagnosis could be the worst depending on your stage at diagnosis.
Melanoma at a glance-
As you can see from the illustration below, the world of skin cancer is wide and complex. To be fair, I cannot blame you for not listening to whatever your oncologist has to say after he/she says “you have skin cancer.” But keep in mind that your diagnosis can run the gamut, according to the study linked and excerpted below from a five year survival rate of over 90% to less than 10% depending on your stage at diagnosis.
I am a long-term cancer survivor and cancer coach. I field questions from cancer patients, survivors and caregivers daily. The majority of questions I’m asked are from cancer patients who don’t know their stage at diagnosis.
Skin Cancer at a glance. Click the image now to see the image enlarged-
The combination of therapies for malignant skin cancer- both conventional (FDA approved) and evidence-based but not FDA approved, is extensive. The five year survival averages listed below take into account only conventional therapies. Not evidence-based Integrative, Complementary and Botanical therapies.
If you would like to learn more about the Skin Cancer Coaching Program that I have researched and developed, click the button on the right side of the page to watch the FREE webinar outlining the SCC Program.
Have you been diagnosed with either melanoma or non-melanoma skin cancer? Scroll down the page, post a question or a comment and I will reply ASAP.
Lesions ≤1 mm in thickness with no evidence of ulceration or metastases (T1aN0M0) are associated with a 5-y survival rate of 95%
Mitotic rate assessment
For mitotic rate assessment, the pathologist counts the number of cells in a certain amount of melanoma tissue that are in the process of dividing. A higher mitotic rate means that the cancer is more likely to grow and spread. The mitotic rate is used to stage thin melanoma.